![Melissa Orilall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Melissa Orilall
Director of Finance/CFO at
MINK THERAPEUTICS, INC.
Net worth: 2 708 $ as of 2026-05-30
Profile
Melissa Orilall currently holds the positions of Vice President-Global Financial Operations at Agenus, Inc. since 2017 and Chief Financial Officer at MiNK Therapeutics, Inc. starting in 2026.
Ms. Orilall completed undergraduate studies at York University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-22 | 222 ( 0% ) | 2 708 $ | 2026-05-30 |
Melissa Orilall active positions
| Companies | Position | Start |
|---|---|---|
| AGENUS INC. | Corporate Officer/Principal | 2016-12-31 |
| MINK THERAPEUTICS, INC. | Director of Finance/CFO | 2026-03-12 |
Training of Melissa Orilall
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
14
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Agenus, Inc.
 Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
York University
 York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MiNK Therapeutics, Inc.
 MiNK Therapeutics, Inc. BiotechnologyHealth Technology Provides bio pharmaceutical services | Health Technology |
- Stock Market
- Insiders
- Melissa Orilall
